Marie.AI: Pioneering Gen AI for diagnostic support.

Marie.AI is our innovative solution to combat the dire health consequences of environmental degradation. With 99% of the world's air deemed unfit for breathing due to deforestation and water pollution, marginalized populations, particularly women and children, bear the brunt of these environmental injustices. To address this pressing issue, we've developed Marie.AI, an advanced artificial intelligence platform tailored to assess pulmonary and metabolic diseases.

Marie.AI operates by analyzing a diverse array of data inputs, including patient history, voice samples, and images of critical anatomical features such as the eyes and mouth. By scrutinizing these data points, Marie.AI identifies patterns and risk factors associated with pulmonary and metabolic diseases. This holistic approach enables healthcare agents and professionals to pinpoint at-risk groups and deliver targeted interventions effectively.

Furthermore, recognizing the importance of real-time data tracking and analysis, we're implementing a public platform integrated with Marie.AI. This platform will provide up-to-date demographic information, including data categorized by age, gender, and ethnicity. By identifying the regions most severely impacted by environmental health crises in real-time, we can mobilize resources and interventions swiftly and efficiently.

One of the primary motivations behind the development of Marie.AI and its accompanying public platform is the recognition of systemic shortcomings in existing health data infrastructure. The data from governmental health agencies, such as the Ministry of Health, often suffer from disorganization and delays in updating. Marie.AI bridges this gap by offering timely and accurate insights, enabling proactive measures to mitigate the health impacts of environmental degradation.

In essence, Marie.AI represents a paradigm shift in healthcare delivery, particularly in underserved communities. By harnessing the power of artificial intelligence and real-time data analysis, we aim to empower healthcare professionals and communities alike to tackle the pressing challenges posed by environmental health hazards.Through Marie.AI and our commitment to leveraging technology for positive social impact, we envision a future where marginalized populations receive equitable access to healthcare and environmental justice becomes a reality for all.

Our solution, Marie.AI, is a cutting-edge artificial intelligence platform designed to revolutionize the assessment and management of pulmonary and metabolic diseases. At its core, Marie.AI utilizes advanced algorithms to analyze diverse data inputs, including patient history, voice samples, and images of key anatomical features such as the eyes and mouth.

By scrutinizing this comprehensive dataset, Marie.AI identifies patterns and risk factors associated with pulmonary and metabolic diseases, empowering healthcare professionals to make informed decisions and provide targeted interventions. This holistic approach ensures that individuals at risk receive timely and personalized care, ultimately improving health outcomes and reducing the burden of disease.

Additionally, Marie.AI is complemented by a public platform that provides real-time tracking of demographic data, including information on age, gender, and ethnicity. This enables proactive measures to be implemented in regions most affected by environmental health hazards, enhancing the effectiveness of interventions and resource allocation.

In essence, Marie.AI represents a paradigm shift in healthcare delivery, leveraging the power of artificial intelligence and real-time data analysis to address the complex challenges posed by environmental degradation and its impact on human health. By providing actionable insights and facilitating informed decision-making, Marie.AI empowers healthcare professionals and communities alike to combat pulmonary and metabolic diseases more effectively.

Through our commitment to innovation and social impact, we envision Marie.AI playing a pivotal role in advancing health equity and environmental justice worldwide. To learn more about Marie.AI and see it in action, please visit

Our solution, Marie.AI, primarily serves marginalized populations disproportionately impacted by environmental degradation and inadequate healthcare access. Specifically, we target communities where the burden of pulmonary and metabolic diseases is exacerbated by factors such as air and water pollution, deforestation, and social inequality. These populations often include women, children, ethnic minorities, and low-income individuals residing in both urban and rural areas.

Currently, these communities face significant barriers to accessing quality healthcare. Limited resources, inadequate infrastructure, and systemic inequalities contribute to disparities in health outcomes, leaving many individuals without the support they need to manage and prevent diseases effectively. Moreover, the lack of timely and accurate data exacerbates these challenges, hindering proactive measures and targeted interventions.

Marie.AI aims to address these issues by providing tailored solutions that meet the specific needs of marginalized populations. By leveraging artificial intelligence and real-time data analysis, Marie.AI offers healthcare professionals actionable insights into the prevalence, risk factors, and trends of pulmonary and metabolic diseases within their communities. This enables targeted interventions to be implemented promptly, ensuring that individuals at risk receive timely diagnosis, treatment, and support.

Furthermore, Marie.AI's public platform enhances transparency and accountability by providing real-time tracking of demographic data. This empowers communities to advocate for their health needs and mobilize resources effectively, fostering a more inclusive and participatory approach to healthcare delivery.

Overall, Marie.AI has the potential to significantly impact the lives of marginalized populations by improving access to quality healthcare, reducing health disparities, and empowering communities to take control of their health outcomes. By addressing the root causes of poor health and promoting proactive interventions, Marie.AI strives to create a more equitable and resilient healthcare system that serves the needs of all individuals, regardless of their socio-economic status or background.

Our team at Marie.AI is uniquely positioned to deliver this solution because of our deep-rooted connection to the communities we aim to serve. Led by individuals who have lived and worked within these communities, we understand the nuanced challenges and needs they face on a daily basis. Our team comprises diverse members who represent the very populations we seek to empower, ensuring that our solution is grounded in real-world experiences and informed by firsthand insights.

As the Team Lead, I have personally experienced the impact of environmental degradation and inadequate healthcare access within marginalized communities. Growing up in a low-income neighborhood, I witnessed the struggles faced by my family and neighbors in accessing quality healthcare and managing chronic diseases exacerbated by environmental factors. This firsthand experience drives my passion and commitment to addressing these issues through innovative solutions like Marie.AI.

Our team members bring a wealth of diverse perspectives and experiences to the table, reflecting the communities we serve. From healthcare professionals with expertise in pulmonology and metabolic disorders to data scientists with a deep understanding of artificial intelligence and machine learning, we have assembled a multidisciplinary team capable of tackling complex challenges from multiple angles.

Crucially, the design and implementation of Marie.AI are guided by meaningful input from the communities we serve. Through extensive community engagement efforts, including focus groups, interviews, and surveys, we have sought to understand the unique needs, priorities, and concerns of our target population. This community-centered approach ensures that our solution is not only technically sound but also culturally sensitive and responsive to the lived experiences of those it seeks to benefit.

Moreover, we are committed to ongoing collaboration and partnership with local healthcare providers, community organizations, and government agencies to co-create and refine our solution. By working hand in hand with stakeholders on the ground, we ensure that Marie.AI remains relevant, effective, and sustainable in addressing the evolving needs of the communities it serves.

In summary, our team's proximity to and deep understanding of the target communities, coupled with our diverse expertise and commitment to community engagement, uniquely qualify us to design and deliver a solution like Marie.AI that addresses the complex challenges of environmental health disparities and improves the lives of marginalized populations.

At the current stage, we have successfully developed and tested the core functionalities of Marie.AI, focusing on its ability to assess pulmonary and metabolic diseases using an integrated approach that includes data analysis, voice recognition, and image assessment. Our team has built and refined the algorithms that power Marie.AI, ensuring accuracy and reliability in identifying patterns and risk factors associated with these diseases.

To validate the effectiveness of our solution, we have conducted pilot studies and trials in collaboration with local healthcare providers and community organizations. These trials have involved collecting data from diverse patient populations, including individuals from underserved communities disproportionately affected by environmental health hazards.

While our customer base is still in its early stages, we have served a significant number of beneficiaries through these pilot studies and trials. Our focus has been on delivering targeted interventions and support to individuals identified as at-risk for pulmonary and metabolic diseases, particularly in regions with high levels of environmental pollution and social inequality.

Through these early implementations, we have been able to gather valuable feedback from both healthcare professionals and community members, allowing us to iterate and improve upon Marie.AI's functionalities. This iterative approach has been instrumental in refining our solution and ensuring its relevance and effectiveness in addressing the needs of our target population.

Overall, our accomplishments thus far demonstrate the feasibility and potential impact of Marie.AI in improving health outcomes for marginalized populations affected by environmental health disparities. As we continue to refine and scale our solution, we are confident that Marie.AI will make a meaningful difference in the lives of those it serves.

I'm signing up to Solve because I believe the platform can be a catalyst to overcome the financial and technical barriers I face in expanding and sustaining the Marie.AI platform in other countries. As an independent researcher, I face significant difficulties in securing the resources necessary to maintain and develop our innovative solution.

Financially, the lack of investment in science and technology in Brazil makes it difficult to obtain financing to expand our platform. Although our business model is sustainable and oriented towards social impact, we do not seek to generate exorbitant dividends, but rather to ensure that our solution is accessible to the population that needs it most. However, even with awards and recognition, the platform does not receive enough investment to sustain its operations and growth.
Technically, we face challenges related to the expansion and continuous improvement of the Marie.AI platform. The current cost of $0.70 per report represents a significant barrier, especially considering the imminent exhaustion of cloud resources in just 4 months. We need marketing and financial support to optimize our processes, reduce operational costs and ensure the scalability of our solution.
In addition to financial and marketing barriers, there are legal and regulatory challenges that we must overcome to ensure compliance with health and safety laws and regulations. Through Solve, I hope to gain guidance and support in navigating these complex aspects and ensuring our platform meets all legal requirements.
In short, I'm signing up to Solve in hopes of gaining financial and strategic support to overcome barriers hindering the growth and sustainability of our Marie.AI platform. I believe Solve can connect us to partners and resources that will help us achieve our goal of promoting the health and well-being of marginalized communities in Brazil and beyond.

Our solution, Marie.AI, stands out for its innovative approach to addressing the complex challenges posed by environmental health disparities and inadequate healthcare access. What sets Marie.AI apart is its integrated and holistic approach to assessing and managing pulmonary and metabolic diseases, leveraging artificial intelligence and real-time data analysis to empower healthcare professionals and communities alike.

Unlike traditional diagnostic methods that rely solely on clinical assessments or laboratory tests, Marie.AI combines multiple data inputs, including patient history, voice samples, and images of key anatomical features such as the eyes and mouth. This comprehensive approach allows Marie.AI to identify patterns and risk factors associated with pulmonary and metabolic diseases more accurately and efficiently, enabling targeted interventions and personalized care plans.

Moreover, Marie.AI's public platform provides real-time tracking of demographic data, allowing for proactive measures to be implemented in regions most affected by environmental health hazards. By promoting transparency, accountability, and community engagement, Marie.AI catalyzes broader positive impacts by fostering collaboration and partnership among healthcare providers, community organizations, and government agencies.

In addition to its immediate benefits for healthcare delivery, Marie.AI has the potential to catalyze broader positive impacts across the healthcare landscape. By demonstrating the effectiveness of artificial intelligence and real-time data analysis in addressing health disparities, Marie.AI can serve as a model for future innovations in healthcare delivery, inspiring other stakeholders to embrace technology-driven solutions to complex health challenges.

Furthermore, Marie.AI has the potential to change the market landscape by disrupting traditional models of healthcare delivery and transforming the way we approach public health interventions. By prioritizing equity, accessibility, and community engagement, Marie.AI challenges existing paradigms and paves the way for more inclusive and sustainable healthcare systems that prioritize the needs of marginalized populations.

Overall, Marie.AI represents a paradigm shift in healthcare delivery, offering a transformative approach to addressing environmental health disparities and improving health outcomes for underserved communities. Through its innovative use of artificial intelligence, real-time data analysis, and community engagement, Marie.AI has the potential to catalyze broader positive impacts and drive meaningful change in the healthcare landscape.

We expect Marie.AI to have a significant impact on the problem of environmental health disparities and inadequate healthcare access by following a clear theory of change:

Marie.AI conducts comprehensive assessments of pulmonary and metabolic diseases using advanced algorithms that analyze various data inputs, including patient history, voice samples, and images of key anatomical features.

The outputs of Marie.AI include accurate identification of patterns and risk factors associated with pulmonary and metabolic diseases, as well as the provision of targeted interventions and personalized care plans for individuals at risk.

By providing healthcare professionals with actionable insights, Marie.AI enables timely diagnosis, treatment, and support for individuals affected by pulmonary and metabolic diseases. This leads to improved health outcomes and reduced morbidity and mortality rates within the target population.

Over time, the use of Marie.AI results in broader positive impacts, including:
   - Increased access to quality healthcare for marginalized populations, particularly women, children, and ethnic minorities.
   - Reduction in health disparities related to environmental factors, such as air and water pollution, deforestation, and social inequality.
   - Empowerment of communities to advocate for their health needs and mobilize resources effectively.
   - Improved public health outcomes and overall well-being within communities affected by environmental health hazards.

This theory of change is supported by evidence from pilot studies, trials, and ongoing evaluations of Marie.AI's effectiveness in real-world settings. Feedback from healthcare professionals and community members further validates the logical links between Marie.AI's activities, outputs, and outcomes, highlighting its potential to drive meaningful change and improve the lives of those it serves.

Our impact goals for Marie.AI are centered around improving health outcomes and reducing health disparities for marginalized populations affected by environmental health hazards. Specifically, we aim to achieve the following:

Our primary goal is to increase access to quality healthcare for marginalized populations, particularly women, children, and ethnic minorities, who are disproportionately affected by pulmonary and metabolic diseases exacerbated by environmental factors. We measure our progress towards this goal by tracking the number of individuals who receive timely diagnosis, treatment, and support through Marie.AI-enabled interventions.

We aim to reduce health disparities related to environmental factors by addressing the root causes of poor health within affected communities. To measure our progress, we track changes in morbidity and mortality rates for pulmonary and metabolic diseases, particularly in regions with high levels of environmental pollution and social inequality.

We seek to empower communities to advocate for their health needs and mobilize resources effectively. We measure our progress towards this goal by assessing community engagement and participation levels, including the number of community members involved in decision-making processes and the implementation of health-related initiatives.

Ultimately, our overarching goal is to improve public health outcomes and overall well-being within communities affected by environmental health hazards. We measure our progress by monitoring key health indicators, such as rates of disease prevalence, health-related quality of life, and access to essential healthcare services.

To track our progress towards these impact goals, we utilize a combination of quantitative and qualitative indicators, including:

- Number of individuals diagnosed and treated for pulmonary and metabolic diseases through Marie.AI-enabled interventions.
- Changes in morbidity and mortality rates for targeted diseases within Marie.AI's target populations.
- Levels of community engagement and participation in health-related initiatives.
- Key health indicators, such as disease prevalence, health-related quality of life, and access to essential healthcare services.

By regularly monitoring and evaluating these indicators, we can assess the effectiveness of Marie.AI in achieving our impact goals and identify areas for improvement and refinement. Additionally, we remain open to feedback from healthcare professionals, community members, and other stakeholders to ensure that our efforts are aligned with the evolving needs of the communities we serve.

Marie.AI relies on artificial intelligence (AI), particularly machine learning algorithms, as its core technology. These algorithms enable the platform to process complex datasets comprising patient history, voice samples, and images of crucial anatomical features like the eyes and mouth. Through this analysis, Marie.AI identifies patterns and risk factors associated with pulmonary and metabolic diseases.

By leveraging machine learning techniques, Marie.AI can recognize correlations, trends, and anomalies indicative of various diseases. With access to labeled datasets, the platform continuously refines its ability to detect relevant patterns, improving accuracy over time. This capability facilitates accurate diagnosis and prognosis, empowering healthcare professionals to tailor personalized care plans for individuals based on their unique health profiles and risk factors.

Furthermore, Marie.AI's AI capabilities extend to real-time monitoring of health trends and disease outbreaks. By analyzing data in real-time, the platform can swiftly detect changes in disease prevalence or severity, enabling proactive interventions and resource allocation. This real-time monitoring also supports community engagement efforts through Marie.AI's public platform, which provides access to demographic data and community health indicators. By visualizing and analyzing this data, Marie.AI empowers communities to understand and advocate for their health needs effectively.

In addition to AI, Marie.AI integrates other modern technologies such as cloud computing and mobile applications. Cloud infrastructure enables scalable data storage and processing, while mobile applications ensure convenient access to Marie.AI's services for healthcare professionals and community members alike.

Overall, Marie.AI harnesses the power of AI and other modern technologies to address the complex challenges of pulmonary and metabolic diseases exacerbated by environmental factors. By leveraging data-driven insights and personalized interventions, Marie.AI seeks to improve health outcomes and reduce health disparities for marginalized populations worldwide.

We have conducted extensive validation and testing processes to ensure the efficacy and accuracy of Marie.AI's technology. Our validation efforts have involved collaborations with healthcare professionals, academic institutions, and community organizations to gather feedback, conduct pilot studies, and evaluate the performance of our platform in real-world settings.

One key aspect of our validation process is the comparison of Marie.AI's diagnostic capabilities against established standards and protocols used in clinical practice. Through comparative studies, we have demonstrated that Marie.AI's AI-powered algorithms achieve comparable or superior performance in identifying patterns and risk factors associated with pulmonary and metabolic diseases.

Furthermore, we have published our findings in peer-reviewed academic journals and presented our research at conferences and symposiums to contribute to the scientific community's understanding of AI-driven healthcare technologies. These publications provide transparent documentation of our methodologies, results, and conclusions, allowing for independent scrutiny and validation by experts in the field.

For example, our recent publication titled "Application of Artificial Intelligence in Pulmonary Disease Diagnosis: A Systematic Review" in the Journal of Medical Artificial Intelligence summarizes the findings of a systematic review evaluating the performance of AI algorithms in diagnosing pulmonary diseases. The study demonstrates the potential of AI-driven technologies, including Marie.AI, in improving diagnostic accuracy and efficiency for respiratory conditions.

Moreover, we have collaborated with healthcare providers and institutions to conduct clinical trials and validation studies involving real patient data. These studies involve blinded assessments by healthcare professionals to evaluate the accuracy and reliability of Marie.AI's diagnostic outputs compared to traditional diagnostic methods.

Additionally, we have engaged in ongoing monitoring and evaluation of Marie.AI's performance in real-world deployments, collecting feedback from users and stakeholders to identify areas for improvement and refinement. This iterative approach ensures that Marie.AI continues to deliver accurate and reliable diagnostic capabilities that meet the needs of healthcare professionals and communities.

Overall, our evidence-based approach to validation, including peer-reviewed publications, clinical trials, and real-world deployments, provides robust evidence of Marie.AI's efficacy and effectiveness in diagnosing pulmonary and metabolic diseases. We remain committed to transparency and accountability in our validation efforts, contributing to the growing body of knowledge on AI-driven healthcare technologies and their potential to transform patient care.

We have two full-time team members dedicated to the development and implementation of our solution, along with three part-time staff members who contribute to various aspects of our project on a flexible basis.

Our team has been working on our solution, Marie.AI, for approximately three years.

Equitable opportunities for career growth and advancement are core principles guiding our organizational practices. We actively identify and address systemic barriers that may hinder certain groups from accessing opportunities for professional development and leadership roles within our organization. Additionally, we cultivate an inclusive environment where all team members feel valued, respected, and supported. Open communication, collaboration, and participation in decision-making processes are encouraged, ensuring that every voice is heard and considered.

Marie.AI plays a crucial role in advancing equity in healthcare by providing support for diagnosis and monitoring of diseases. This technology-driven approach ensures that individuals, regardless of their background or location, have access to timely and accurate healthcare services. By leveraging artificial intelligence and real-time data analysis, Marie.AI removes barriers to healthcare access and empowers marginalized populations to take control of their health.

Recognizing that DEI is an ongoing journey, we are committed to continuous improvement. We regularly seek feedback from team members and stakeholders to identify areas for enhancement and implement strategies to address them. Community engagement is integral to our approach, as we actively collaborate with community organizations, advocate for inclusive policies, and amplify the voices of underrepresented groups.

Partnerships and collaborations with like-minded organizations further bolster our commitment to DEI. By pooling resources and expertise, we can drive meaningful change and create more inclusive environments together. Ultimately, we view diversity, equity, and inclusion as essential components of our organizational culture, embedded into every aspect of our work. Our team's diversity is not just a goal but a source of strength and innovation, propelling us towards our shared mission of creating positive impact in our communities.

Our business model revolves around leveraging technology, especially our AI-powered platform, Marie.AI, to reduce healthcare costs associated with diagnostic procedures for pulmonary and metabolic diseases. We provide value to healthcare providers, patients, and healthcare systems by offering accurate and efficient diagnostic support services at a lower cost compared to traditional diagnostic methods.

We offer diagnostic support services through Marie.AI, which analyzes patient data, including medical history, voice samples, and images, to assist healthcare providers in diagnosing pulmonary and metabolic diseases accurately. By utilizing advanced AI algorithms, Marie.AI streamlines the diagnostic process, reducing the need for expensive and invasive diagnostic tests.

Our business model focuses on reducing healthcare costs associated with diagnostic procedures. By providing an affordable alternative to costly diagnostic tests, such as imaging scans and laboratory tests, we enable healthcare providers to deliver high-quality care while minimizing financial burdens on patients and healthcare systems.

Marie.AI improves diagnostic efficiency and accuracy by leveraging AI technology to analyze large datasets rapidly and identify patterns indicative of pulmonary and metabolic diseases. By providing timely and accurate diagnostic support, we help healthcare providers make informed treatment decisions, leading to improved patient outcomes and reduced healthcare costs over the long term.

We offer our diagnostic support services to healthcare providers through a subscription-based model. Healthcare facilities pay a recurring fee to access Marie.AI's platform and utilize its diagnostic support services as needed. This model allows healthcare providers to budget effectively for diagnostic support services while ensuring a steady revenue stream for our business.

We collaborate with healthcare facilities, clinics, and medical practices to integrate Marie.AI's diagnostic support services into their existing workflows. By partnering with healthcare providers, we expand our reach and impact, making our services accessible to a broader population of patients in need of affordable and accurate diagnostic support.

Overall, our business model is centered around leveraging technology to reduce healthcare costs, improve diagnostic accuracy, and enhance patient outcomes. By providing cost-effective diagnostic support services through Marie.AI, we aim to make high-quality healthcare more accessible and affordable for patients while supporting the sustainability of healthcare systems globally.

Our plan for achieving financial sustainability involves a strategic approach to revenue generation tailored to our target market and the unique value proposition of our solution. We aim to secure our financial future through several key strategies.

Firstly, we offer our diagnostic support services to healthcare providers through a subscription-based model. Healthcare facilities pay a recurring fee to access Marie.AI's platform and utilize its diagnostic support services as needed. This approach ensures a consistent revenue stream for our business while providing our clients with budget predictability and flexibility.

Additionally, we actively seek partnerships and collaborations with healthcare facilities, clinics, and medical practices to integrate Marie.AI's diagnostic support services into their existing workflows. Through these partnerships, we generate revenue through service contracts and licensing agreements, leveraging our technology to improve healthcare outcomes and create value for our partners.

Furthermore, we pursue grants and funding opportunities to support our research and development efforts and expand our reach and impact. Securing grants from organizations such as FAPESP demonstrates our ability to attract funding to sustain our operations and advance our mission.

While we are currently self-funded, we remain open to raising investment capital to accelerate our growth and scale our operations strategically. By pursuing investment opportunities that align with our mission and vision, we aim to achieve greater impact and expand our reach.

Finally, as part of our commitment to equity and inclusion, we offer discounted or subsidized access to our diagnostic support services for low-income clients. By ensuring affordability and accessibility, we aim to reach underserved populations and fulfill our social mission while generating revenue through volume-based models.

Evidence of our plan's success includes revenue generated through subscription fees, successful partnerships and collaborations resulting in service contracts and licensing agreements, grants and funding secured to support our research and development efforts, and continued growth and expansion of our user base. These indicators demonstrate the value and demand for our services in the market and our ability to achieve financial sustainability while advancing our mission of improving healthcare outcomes through innovative technology solutions.